12 results
8-K
EX-3.2
IMNM
Immunome, Inc.
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
8-K
EX-3.3
IMNM
Immunome, Inc.
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
8-K
EX-3.4
IMNM
Immunome, Inc.
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
8-K
EX-3.1
IMNM
Immunome, Inc.
6 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-3.2
IMNM
Immunome, Inc.
6 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
S-1/A
EX-3.1
7rjv8tgtnvddocdk0
24 Sep 20
IPO registration (amended)
7:18am
S-1
EX-3.4
fhc47s2kln9zdq28gjv
9 Sep 20
IPO registration
4:19pm
S-1
EX-3.3
tgsfui1
9 Sep 20
IPO registration
4:19pm
S-1
EX-3.2
m0uvfcqvhdwdnfubbuk
9 Sep 20
IPO registration
4:19pm
S-1
EX-3.1
3w9wbsu93aj4 h9
9 Sep 20
IPO registration
4:19pm
DRS
EX-3.1
k9ev 4d83zfvxhxcz
12 Aug 20
Draft registration statement
12:00am
DRS
EX-3.2
gpb9de lwg1
12 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next